Evidence map›Paper›PMID 26604335›Full record

ReviewJournal of food science and technology2015

Probiotics, prebiotics and synbiotics- a review.

Kavita R Pandey, Suresh R Naik, Babu V Vakil

3 registry-linked trialsAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of food science and technology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 487 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
487citing papers in PubMed, 14 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05885373 nacompletednot on this mapstarted 2023, after this paper: background citation

A Single-arm, Open-label Clinical Study to Evaluate the Effect of SIM01 in Female Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

TypeinterventionalSponsorGenieBiome LimitedRan2023 to 2023Enrolled40ConditionsNon-Alcoholic Fatty Liver DiseaseArmsSIM01
NCT06537882 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

A Double-blind Randomized Placebo-controlled Study to Evaluate the Effect of Synbiotics SLP07 on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD-RCT)

TypeinterventionalSponsorGenieBiome LimitedRan2024 to 2026Enrolled54ConditionsMetabolic Dysfunction-Associated Fatty Liver DiseaseArmsG-NiiB synbiotics formula (SLP07), Active placebo
NCT06620406 nacompletednot on this mapstarted 2024, after this paper: background citation

Pilot Study of Synbiotic Therapy for Neuropsychiatric PASC

TypeinterventionalSponsorColumbia UniversityRan2024 to 2025Enrolled36ConditionsPost-Acute COVID-19 Syndrome, Long COVID-19ArmsSynbiotic IVS-1, Maltodextrin
3 · Its place in the literature

Who cites it

487 citing papers in PubMed, 14 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

427 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kavita R PandeyGNIRD, Guru Nanak Khalsa College of arts science and Commerce, NP Marg, Opp. Don Bosco school, Matunga east, Mumbai, 400019 India.
Suresh R NaikGNIRD, Guru Nanak Khalsa College of arts science and Commerce, NP Marg, Opp. Don Bosco school, Matunga east, Mumbai, 400019 India.
Babu V VakilGNIRD, Guru Nanak Khalsa College of arts science and Commerce, NP Marg, Opp. Don Bosco school, Matunga east, Mumbai, 400019 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The health benefits imparted by probiotics and prebiotics as well as synbiotics have been the subject of extensive research in the past few decades. These food supplements termed as functional foods have been demonstrated to alter, modify and reinstate the pre-existing intestinal flora. They also facilitate smooth functions of the intestinal environment. Most commonly used probiotic strains are: Bifidobacterium, Lactobacilli, S. boulardii, B. coagulans. Prebiotics like FOS, GOS, XOS, Inulin; fructans are the most commonly used fibers which when used together with probiotics are termed synbiotics and are able to improve the viability of the probiotics. Present review focuses on composition and roles of Probiotics, Prebiotics and Synbiotics in human health. Furthermore, additional health benefits like immune-modulation, cancer prevention, inflammatory bowel disease etc. are also discussed. Graphical abstractPictorial summary of health benefits imparted by probiotics, prebiotics and synbiotics.

Indexed as

CancerCardiovascular diseasesIntestinal disordersPrebioticsProbioticsSynbiotics

Identifiers

PMID26604335
PMCPMC4648921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.